| Myopenia and Mechanisms of Chemotherapy Toxicity in Older Adults With Colorectal Cancer |
|
Recruiting |
| Naloxegol in Treating Patients With Stage IIIB-IV Non-small Cell Lung Cancer |
Naloxegol, Placebo, Laboratory Biomarker Analysis, Quality-of-Life Assessment |
Active, not recruiting |
| National Cancer Institute "Cancer Moonshot Biobank" |
Biospecimen Collection, Medical Chart Review |
Recruiting |
| NCI COVID-19 in Cancer Patients, NCCAPS Study |
Biospecimen Collection, Data Collection, Quality-of-Life Assessment, Questionnaire Administration |
Active, not recruiting |
| Neuropsychological and Behavioral Testing in Younger Patients With Cancer |
Cognitive Assessment, Quality-of-Life Assessment |
Active, not recruiting |
| New Assessment System in Measuring Symptom Distress in Cancer Patients |
Interview, Quality-of-Life Assessment, Questionnaire Administration |
Recruiting |
| Nilotinib in Preventing Paclitaxel-Induced Peripheral Neuropathy in Patients With Stage I-III Breast Cancer |
Questionnaire Administration, Paclitaxel, Placebo, Nilotinib, Nilotinib Hydrochloride Monohydrate |
Recruiting |
| Nutrition Therapy in Improving Immune System in Patients With Bladder Cancer That Can Be Removed by Surgery |
Laboratory Biomarker Analysis, Nutritional Intervention, Placebo Administration, Quality-of-Life Assessment, Questionnaire Administration |
Active, not recruiting |
| Olanzapine Versus Megestrol Acetate for the Treatment of Loss of Appetite Among Advanced Cancer Patients |
Megestrol Acetate, Olanzapine, Questionnaire Administration |
Recruiting |
| Palbociclib and Letrozole or Fulvestrant in Treating Patients With Estrogen Receptor Positive, HER2 Negative Metastatic Breast Cancer |
Fulvestrant, Letrozole, Palbociclib, Quality-of-Life Assessment, Questionnaire Administration |
Active, not recruiting |